![Terremoto Biosciences](https://www.impactnews-wire.com/wp-content/uploads/2023/11/blob-3f980d6.png)
Terremoto Biosciences Closes $175 Million Series B Financing
– Proceeds to advance the company’s platform and support the progress of multiple in-house discovery and development programs targeting diseases of high unmet medical need – Participating investors include EcoR1 Capital, Novo Holdings, Cormorant Capital, OrbiMed and Third Rock Ventures November 02, 2023 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, today announced the closing … Continue reading Terremoto Biosciences Closes $175 Million Series B Financing